Inhibition of lipid raft-dependent signaling by a dystrophy-associated mutant of caveolin-3

J Biol Chem. 2002 May 17;277(20):17944-9. doi: 10.1074/jbc.M110879200. Epub 2002 Mar 7.

Abstract

Specific point mutations in caveolin-3, a predominantly muscle-specific member of the caveolin family, have been implicated in limb-girdle muscular dystrophy and in rippling muscle disease. We examined the effect of these mutations on caveolin-3 localization and function. Using two independent assay systems, Raf activation in fibroblasts and neurite extension in PC12 cells, we show that one of the caveolin-3 point mutants, caveolin-3-C71W, specifically inhibits signaling by activated H-Ras but not by K-Ras. To gain insights into the effect of the mutant protein on H-Ras signaling, we examined the localization of the mutant proteins in fibroblastic cells and in differentiating myotubes. Unlike the previously characterized caveolin-3-DGV mutant, the inhibitory caveolin-3-C71W mutant reached the plasma membrane and colocalized with wild type caveolins. In BHK cells, caveolin-3-C71W associated with caveolae and in differentiating muscle cells with the developing T-tubule system. In contrast, the caveolin-3-P104L mutant accumulated in the Golgi complex and had no effect on H-Ras-mediated Raf activation. Inhibition by caveolin-3-C71W was rescued by cholesterol addition, suggesting that the mutant protein perturbs cholesterol-rich raft domains. Thus, we have demonstrated that a naturally occurring caveolin-3 mutation can inhibit signaling involving cholesterol-sensitive raft domains.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Caveolin 3
  • Caveolins / genetics*
  • Caveolins / pharmacology*
  • Cell Line
  • Cholesterol / pharmacology*
  • Cricetinae
  • Genes, ras
  • Golgi Apparatus / metabolism
  • Membrane Microdomains / drug effects*
  • Muscles / metabolism
  • Muscular Dystrophies / genetics
  • Muscular Dystrophies / metabolism*
  • PC12 Cells
  • Point Mutation
  • Rats
  • Signal Transduction / drug effects*

Substances

  • Cav3 protein, rat
  • Caveolin 3
  • Caveolins
  • Cholesterol